Ignite Creation Date:
2025-12-25 @ 3:27 AM
Ignite Modification Date:
2026-03-03 @ 5:04 AM
Study NCT ID:
NCT01314105
Status:
COMPLETED
Last Update Posted:
2025-02-13
First Post:
2011-03-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
BIBF 1120 + Carboplatin/Pegylated Liposomal Doxorubicin (PLD) in Patients With Advanced Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Cancer
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-03-15
Start Date Type:
ACTUAL
Primary Completion Date:
2013-07-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-04-04
Completion Date Type:
ACTUAL
First Submit Date:
2011-03-08
First Submit QC Date:
None
Study First Post Date:
2011-03-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-11-14
Results First Submit QC Date:
None
Results First Post Date:
2014-11-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-29
Last Update Post Date:
2025-02-13
Last Update Post Date Type:
ACTUAL